BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 14655194)

  • 21. Effects of Lowering Dialysate Calcium Concentration on Mineral and Bone Disorders in Chronic Hemodialysis Patients: Conversion from 3.0 mEq/L to 2.75 mEq/L.
    Yamada S; Ueki K; Tokumoto M; Suehiro T; Kimura H; Taniguchi M; Fujimi S; Kitazono T; Tsuruya K
    Ther Apher Dial; 2016 Feb; 20(1):31-9. PubMed ID: 26482334
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The PTH-calcium relationship curve in secondary hyperparathyroidism, an index of sensitivity and suppressibility of parathyroid glands.
    Caligara F; Giangrande A; Allaria P; Castiglioni A
    Nephrol Dial Transplant; 1996; 11 Suppl 3():136-41. PubMed ID: 8840329
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of calcitriol and age on recovery from hypocalcemia in hemodialysis patients.
    Borrego MJ; Martin-Malo A; Almaden Y; Rodriguez M; Aljama P; Felsenfeld AJ
    Am J Kidney Dis; 1999 Sep; 34(3):456-63. PubMed ID: 10469855
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Parathyroid hormone during maintenance dialysis: influence of low calcium dialysate, plasma albumin and age.
    Heaf JG; Løkkegård H
    J Nephrol; 1998; 11(4):203-10. PubMed ID: 9702872
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of chronic intravenous calcitriol on parathyroid function and set point of calcium in dialysis patients with refractory secondary hyperparathyroidism.
    Malberti F; Surian M; Cosci P
    Nephrol Dial Transplant; 1992; 7(8):822-8. PubMed ID: 1325615
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Improvement of secondary hyperparathyroidism and reduction of the set point of calcium after intravenous calcitriol.
    Malberti F; Surian M; Cosci P
    Kidney Int Suppl; 1993 Jun; 41():S125-30. PubMed ID: 8320905
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of calcitriol on parathyroid function and on bone remodelling in secondary hyperparathyroidism.
    Costa AF; dos Reis LM; Ribeiro MC; Moysés RM; Jorgetti V
    Nephrol Dial Transplant; 2003 Apr; 18(4):743-9. PubMed ID: 12637644
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reversibility of experimental secondary hyperparathyroidism.
    Lewin E; Wang W; Olgaard K
    Kidney Int; 1997 Nov; 52(5):1232-41. PubMed ID: 9350646
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of vitamin C on parathyroid hormone in hemodialysis patients with mild to moderate secondary hyperparathyroidism.
    Sanadgol H; Bayani M; Mohammadi M; Bayani B; Mashhadi MA
    Iran J Kidney Dis; 2011 Nov; 5(6):410-5. PubMed ID: 22057074
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Hyperparathyroidism secondary to renal insufficiency. Physiopathology, clinicoradiological aspects and treatment].
    Ben Hamida F; Ghazali A; Boudzernidj M; Amar M; Morinière P; Westeel P; Fournier A
    Ann Endocrinol (Paris); 1994; 55(5):147-58. PubMed ID: 7857079
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Individualization of dialysate calcium concentration according to baseline pre-dialysis serum calcium.
    Gonzalez-Parra E; Gonzalez-Casaus ML; Arenas MD; Sainz-Prestel V; Gonzalez-Espinoza L; Muñoz-Rodriguez MA; Tabikh A; Egido J; Ortiz A
    Blood Purif; 2014; 38(3-4):224-33. PubMed ID: 25531119
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Rate dependence of acute PTH release and association between basal plasma calcium and set point of calcium-PTH curve in dialysis patients.
    De Cristofaro V; Colturi C; Masa A; Comelli M; Pedrini LA
    Nephrol Dial Transplant; 2001 Jun; 16(6):1214-21. PubMed ID: 11390723
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The set point of calcium and the reduction of parathyroid hormone in hemodialysis patients.
    Pahl M; Jara A; Bover J; Rodriguez M; Felsenfeld AJ
    Kidney Int; 1996 Jan; 49(1):226-31. PubMed ID: 8770972
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treatment of secondary hyperparathyroidism in hemodialyzed patients with high-dose calcium carbonate without vitamin D3 supplements.
    Teruel JL; Tenorio MT; Rodríguez JR; Marc n R; Orofino L; Rivera M; Ortuño J
    Am J Nephrol; 1999; 19(3):428-32. PubMed ID: 10393383
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of calcitriol treatment and withdrawal on hyperparathyroidism in haemodialysis patients with hypocalcaemia.
    Jara A; Chacón C; Valdivieso A; Aris L; Jalil R; Felsenfeld AJ
    Nephrol Dial Transplant; 2001 May; 16(5):1009-16. PubMed ID: 11328908
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Parathyroid gland function in chronic renal failure.
    Felsenfeld AJ; Llach F
    Kidney Int; 1993 Apr; 43(4):771-89. PubMed ID: 8479113
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Low-calcium dialysate stimulates parathormone secretion and its long-term use worsens secondary hyperparathyroidism.
    Fernández E; Borràs M; Pais B; Montoliu J
    J Am Soc Nephrol; 1995 Jul; 6(1):132-5. PubMed ID: 7579066
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intravenous calcitriol for treatment of hyperparathyroidism in children on hemodialysis.
    Greenbaum LA; Grenda R; Qiu P; Restaino I; Wojtak A; Paredes A; Benador N; Melnick JZ; Williams LA; Salusky IB
    Pediatr Nephrol; 2005 May; 20(5):622-30. PubMed ID: 15785941
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The negative Ca(2+) balance is involved in the stimulation of PTH secretion.
    Yokoyama K; Kagami S; Ohkido I; Kato N; Yamamoto H; Shigematsu T; Nakayama M; Fukagawa M; Kawaguchi Y; Hosoya T
    Nephron; 2002 Sep; 92(1):86-90. PubMed ID: 12187089
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effect of long-term intravenous calcitriol administration on parathyroid function in hemodialysis patients.
    Rodriguez M; Felsenfeld AJ; Williams C; Pederson JA; Llach F
    J Am Soc Nephrol; 1991 Nov; 2(5):1014-20. PubMed ID: 1760537
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.